Welcome : Guest

CareDx, Inc. (USA) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about CareDx, Inc., which is principally a Molecular Diagnostics Company. Illustrated with 23 tables, the report showcases the company's sales performance, key markets and market position as against its competitors operating in the industry.

Code: PCP-63962
Price: $1150
Company Type: Public
Pages: 26
Date: November 2016
Market Data Tables: 23

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Table 1: CareDx, Inc.’s Revenues by Category (2014-2015) in Percentage for Testing Revenue, and Collaboration and License Revenue......3
Molecular Diagnostics......5
Table 2: Global Molecular Diagnostics (MDx) Market by Infectious Diseases Therapeutic Area (2015) - Percentage Share Breakdown by Value Sales for CT/NG, Healthcare-associated Infections (HAI), Hepatitis, HIV, Respiratory and Others......5
Table 3: Global Molecular Diagnostics (MDx) Market by Region (2015) - Percentage Breakdown by Value Sales for Americas, EMEA and Pacific......6
Table 4: Molecular Diagnostic Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Disease Inherited, Infectious Diseases, Oncology, Prenatal, and Tissue Typing......7
Table 5: Molecular Diagnostics (MDx) Market by Location of Test Worldwide (2015) - Percentage Share Breakdown by Value Sales for Blood Banks, Hospitals, Near-Patient, and Reference Labs......8
Table 6: Molecular Diagnostics (MDx) Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Bacteriology, Blood Screening, Genomics and Virology......9
Table 7: Molecular Diagnostics (MDx) Market by Technology Worldwide (2015) - Percentage Share Breakdown by Value Sales for Beads, CE Sequencing, Hybrid Capture, ISH, Microarrays, NGS, PCR, Qpcr, TMA, and Others......10
Table 8: Molecular Diagnostics (MDx) Market by Therapeutic Area Worldwide (2015) - Percentage Share Breakdown by Value Sales for Blood Screening, CT / NG, HAIs, HLA, HPV, Oncology, Viral Load, and Others......11
Table 9: Molecular Diagnostics (MoDx) Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for Europe, Japan, Korea, US, and Others......12
Table 10: Molecular Diagnostics Infectious Diseases Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value Sales for Active Tuberculosis, Blood Banking, Chlamydia trachomatis (CT), and Neisseria gonorrhoeae (NG), Clostridium difficile, Human Papillomavirus (HPV), Influenza, Panels, S. aureus (SA), and methicillin-resistant S. aureus (MRSA), Viral Load, and Others......13
Table 11: Molecular Diagnostics Market by Application Worldwide (2015) - Percentage Share Breakdown by Value for Blood Screening, Genetics, Infectious Disease, Oncology and Others......14
Table 12: Molecular Diagnostics Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Biochip and Lab-on-a-Chip (LOAC), In Situ Hybridization (ISH), Microarrays, Polymerase Chain Reaction (PCR) and Others......15
Table 13: Molecular Diagnostics Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value Sales for Infectious Diseases, Inherited Disease, Oncology, Prenatal and Tissue Typing......16
Table 14: Molecular Diagnostics Test Market by Type in Europe (2015) - Percentage Share Breakdown by Volume for Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG), Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), Human Immunodeficiency Virus (HIV), Methicillin-resistant Staphylococcus aureus (MRSA) and Others......17
Table 15: Molecular Diagnostics Lab Market by Test Complexity in the US (2015) - Percentage Share Breakdown by Volume for Highly Complex w/LDT, Highly Complex, no LDT and Moderately Complex......18
Table 16: Molecular Diagnostics Lab Market by Test Type in the US (2015) - Percentage Share Breakdown by Volume for Both ID & Genetics, Disease, Only and Infectious......19
Table 17: Molecular Diagnostics Market by Segment in the US (2015) - Percentage Share Breakdown by Value Sales for Blood Screening, Genetic Testing Order, Oncology, Virology and Other Infectious Diseases......20
Table 18: Number of Molecular Diagnostics Laboratories by CLIA Complexity in the US (2015) - Percentage Market Share Breakdown for Highly Complex, No Laboratory-Developed Test (LDT), Highly Complex, With Laboratory-Developed Test (LDT) and Moderately Complex......21
Table 19: Number of Molecular Diagnostics Laboratories by Testing Type in the US (2015) - Percentage Market Share Breakdown for Genetics Only, Infectious Disease Only and Both Infectious Disease and Genetics......22
Spending on Molecular Diagnostics......23
Table 20: Spending on Molecular Diagnostics and Genetic Testing by Payer in the US (2015) - Percentage Market Share Breakdown by Value for Cancer, Infectious Diseases, Inhired Conditions and Other......23
Molecular Diagnostics......24
Table 21: Market Shares of Leading Molecular Diagnostic Product Manufacturers Worldwide (2015) - Percentage Share Breakdown by Value for Abbott Laboratories, Bayer AG, Becton, Dickinson and Company, F. Hoffmann-La Roche AG, Hologic Corporation, Novartis International AG, Qiagen, and Others......24
Table 22: Market Shares of Leading Molecular Diagnostics (MDx) Companies by Value Sales Worldwide (2014) - Percentage Breakdown for Abbott Laboratories, Becton, Dickinson and Co., Cepheid, F. Hoffmann-La Roche Ltd., Hologic Gen-Probe, Inc., Novartis AG, Qiagen N.V., Siemens AG and Others......25
Table 23: Market Shares of Leading Molecular Diagnostics (MDx) Equipment Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Abbott Laboratories, Becton, Dickinson and Company, Cepheid, Inc., Hologic, Inc., Illumina, Inc., Qiagen N.V., Rogers Corporation, Siemens AG, Thermo Fisher Scientific, and Others......26